Giulia Picozzi
Overview
Explore the profile of Giulia Picozzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
476
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mascalchi M, Cavigli E, Picozzi G, Cozzi D, De Luca G, Diciotti S
J Thorac Imaging
. 2024 Sep;
PMID: 39267479
Purpose: Lesion overlooking and late diagnostic workup can compromise the efficacy of low-dose CT (LDCT) screening of lung cancer (LC), implying more advanced and less curable disease stages. We hypothesized...
2.
Mascalchi M, Puliti D, Cavigli E, Cortes-Ibanez F, Picozzi G, Carrozzi L, et al.
Eur J Radiol
. 2024 Aug;
179:111679.
PMID: 39163805
Purpose: To investigate the early radiological features and survival of Large Cell Carcinoma (LCC) cases diagnosed in low-dose computed tomography (LDCT) screening trials. Methods: Two radiologists jointly reviewed the radiological...
3.
Bisanzi S, Puliti D, Picozzi G, Romei C, Pistelli F, Deliperi A, et al.
Cancers (Basel)
. 2024 Jun;
16(12).
PMID: 38927981
The role of total plasma cell-free DNA (cfDNA) in lung cancer (LC) screening with low-dose computed tomography (LDCT) is uncertain. We hypothesized that cfDNA could support differentiation between malignant and...
4.
Mascalchi M, Picozzi G, Puliti D, Diciotti S, Deliperi A, Romei C, et al.
Diagnostics (Basel)
. 2023 Jul;
13(13).
PMID: 37443590
The ITALUNG trial started in 2004 and compared lung cancer (LC) and other-causes mortality in 55-69 years-aged smokers and ex-smokers who were randomized to four annual chest low-dose CT (LDCT)...
5.
Mascalchi M, Romei C, Marzi C, Diciotti S, Picozzi G, Pistelli F, et al.
Eur Radiol
. 2023 Mar;
33(5):3115-3123.
PMID: 36854875
Objectives: Cardiovascular disease (CVD), lung cancer (LC), and respiratory diseases are main causes of death in smokers and former smokers undergoing low-dose computed tomography (LDCT) for LC screening. We assessed...
6.
Mascalchi M, Picozzi G, Puliti D, Gorini G, Mantellini P, Sali L
Diagnostics (Basel)
. 2022 Oct;
12(10).
PMID: 36292015
Annual screening of lung cancer (LC) with chest low-dose computed tomography (CT) and screening of colorectal cancer (CRC) with CT colonography every 5 years are recommended by the United States...
7.
Low-dose CT for lung cancer screening: position paper from the Italian college of thoracic radiology
Silva M, Picozzi G, Sverzellati N, Anglesio S, Bartolucci M, Cavigli E, et al.
Radiol Med
. 2022 Mar;
127(5):543-559.
PMID: 35306638
Smoking is the main risk factor for lung cancer (LC), which is the leading cause of cancer-related death worldwide. Independent randomized controlled trials, governmental and inter-governmental task forces, and meta-analyses...
8.
Puliti D, Picozzi G, Gorini G, Carrozzi L, Mascalchi M
Lancet Reg Health Eur
. 2022 Jan;
13:100300.
PMID: 35024679
No abstract available.
9.
Mascalchi M, Puliti D, Romei C, Picozzi G, De Liperi A, Diciotti S, et al.
Eur J Radiol
. 2021 Nov;
145:110040.
PMID: 34814037
Purpose: Coronary artery calcifications (CAC) are very strong indicators for increased cardio-vascular (CV) risk and can be evaluated also in low-dose computed tomography (LDCT) for lung cancer screening. We assessed...
10.
Paci E, Puliti D, Carozzi F, Carrozzi L, Falaschi F, Pegna A, et al.
J Med Screen
. 2020 May;
28(1):39-47.
PMID: 32437229
Objectives: Overdiagnosis in low-dose computed tomography randomized screening trials varies from 0 to 67%. The National Lung Screening Trial (extended follow-up) and ITALUNG (Italian Lung Cancer Screening Trial) have reported...